Skip to main content
. 2016 Mar 22;11(3):e0151828. doi: 10.1371/journal.pone.0151828

Table 1. Demographic, clinical, serological and virological characteristics of the 317 patients infected with HCV.

Factor Number or Median [Interquartile range]
Age, years 57 [45–64]
Gender, male/female 167/150
Liver histology,
 F0/1/2/3/4 7/149/87/58/16
 A0/1/2/3 5/178/133/1
HCV RNA, <4.9/≥5.0 LogIU/mL 34/283
Alcohol, none/drinking/unknown 99/73/145
HBsAg, +/- 0/317
Anti-nuclear antibody, <40/40≤/unknown 246/35/36
Hemoglobin, g/dL 14.2 [13.3–15.4]
Platelet count, ×104/μL 15.7 [12.1–20.5]
Prothrombin time, % 92 [83–100]
Total bilirubin, mg/dL 0.7 [0.5–0.9]
Aspartate aminotransferase, U/L 52 [35–78]
Alanine aminotransferase, U/L 64 [41–101]
Serum total protein, g/dL 7.5 [7.2–7.9]
Serum albumin, g/dL 4.1 [3.9–4.3]
Blood urea nitrogen, mg/dL 13.8 [11.5–16.2]
Creatinine, mg/dL 0.67 [0.57–0.77]
Hyaluronic acid, ng/mL (missing value, n = 74) 65.7 [26.3–155.8]
Alpha fetoprotein, ng/mL 5.6 [3.3–11]
Fucosylated haptoglobin, U/mL 559 [304–1135]
Mac-2 binding protein, ng/mL 1847 [1022–3021]